ARCHIVES

FDA Approves Gleevec In 73 Days, A Speed Record.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009

In Brief: Bertino Moves To MSK As Head Of Chemotherapy Research; Rosemary Clive Laves ACOS For Elm

January 2, 1987

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

The FY 1984 Bypass Budget: How NCI Would Spend the Money

July 9, 1982

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

October 31, 2003

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014